Exagen (XGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.72, -9.81% vs the prior close of $8.56.
- Volume 965.81K shares, 3.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XGN slides 9.8% to $7.72, a 1-month low on 3.1x normal volume. Closed at $7.72, -9.81% vs the prior close of $8.56. Day range $7.35–$8.55, opened at $8.46.
XGN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — XGN slides 9.8% to $7.72, a 1-month low on 3.1x normal volume
- Closed at $7.72, -9.81% vs the prior close of $8.56. Day range $7.35–$8.55, opened at $8.46.
- Volume was 965.81K shares, 3.1x its 50-day average of 308.68K — unusually heavy trading.
- Price is -0.1% vs its 50-day average ($7.73) and +56.6% vs its 200-day average ($4.93).
- 52-week range $2.59–$12.23; today's close sits at 53% of that range, 36.9% below the 52-week high.
Oct 15, 2026 — XGN rises 1.7% to $8.56
- Closed at $8.56, +1.66% vs the prior close of $8.42. Day range $8.17–$8.63, opened at $8.34.
- Volume was 393.90K shares, 1.2x its 50-day average of 325.25K.
- Price is +11.1% vs its 50-day average ($7.70) and +74.0% vs its 200-day average ($4.92).
- 52-week range $2.59–$12.23; today's close sits at 62% of that range, 30.0% below the 52-week high.
Oct 14, 2026 — XGN dips 0.7% to $8.42
- Closed at $8.42, -0.71% vs the prior close of $8.48. Day range $8.32–$9.22, opened at $8.35.
- Volume was 611.80K shares, 1.7x its 50-day average of 367.94K.
- Price is +9.9% vs its 50-day average ($7.66) and +71.6% vs its 200-day average ($4.91).
- 52-week range $2.59–$12.23; today's close sits at 60% of that range, 31.2% below the 52-week high.
Oct 13, 2026 — XGN rises 2.8% to $8.48
- Closed at $8.48, +2.79% vs the prior close of $8.25. Day range $8.13–$8.66, opened at $8.18.
- Volume was 470.00K shares, 1.3x its 50-day average of 362.78K.
- Price is +11.2% vs its 50-day average ($7.63) and +73.2% vs its 200-day average ($4.90).
- 52-week range $2.59–$12.23; today's close sits at 61% of that range, 30.7% below the 52-week high.
Oct 12, 2026 — XGN dips 2.0% to $8.25
- Closed at $8.25, -2.02% vs the prior close of $8.42. Day range $8.11–$8.49, opened at $8.20.
- Volume was 201.10K shares, 0.6x its 50-day average of 360.89K — lighter than usual.
- Price is +9.3% vs its 50-day average ($7.55) and +68.9% vs its 200-day average ($4.88).
- 52-week range $2.59–$12.23; today's close sits at 59% of that range, 32.5% below the 52-week high.
Oct 9, 2026 — XGN jumps 3.1% to $8.42
- Closed at $8.42, +3.06% vs the prior close of $8.17. Day range $7.98–$8.55, opened at $8.17.
- Volume was 251.20K shares, 0.7x its 50-day average of 357.84K.
- Price is +12.6% vs its 50-day average ($7.47) and +72.7% vs its 200-day average ($4.87).
- 52-week range $2.59–$12.23; today's close sits at 60% of that range, 31.2% below the 52-week high.
Oct 8, 2026 — XGN dips 1.6% to $8.17
- Closed at $8.17, -1.57% vs the prior close of $8.30. Day range $7.98–$8.25, opened at $8.24.
- Volume was 362.30K shares, 1.0x its 50-day average of 354.37K.
- Price is +10.4% vs its 50-day average ($7.40) and +67.9% vs its 200-day average ($4.87).
- 52-week range $2.59–$12.23; today's close sits at 58% of that range, 33.2% below the 52-week high.
Oct 7, 2026 — XGN rises 1.3% to $8.30
- Closed at $8.30, +1.34% vs the prior close of $8.19. Day range $7.89–$8.36, opened at $7.98.
- Volume was 234.90K shares, 0.7x its 50-day average of 355.07K.
- Price is +13.3% vs its 50-day average ($7.32) and +70.9% vs its 200-day average ($4.86).
- 52-week range $2.59–$12.23; today's close sits at 59% of that range, 32.1% below the 52-week high.
Oct 6, 2026 — XGN slides 3.2% to $8.19
- Closed at $8.19, -3.19% vs the prior close of $8.46. Day range $8.09–$8.70, opened at $8.53.
- Volume was 271.80K shares, 0.8x its 50-day average of 353.67K.
- Price is +13.0% vs its 50-day average ($7.25) and +69.0% vs its 200-day average ($4.85).
- 52-week range $2.59–$12.23; today's close sits at 58% of that range, 33.0% below the 52-week high.
Oct 5, 2026 — XGN jumps 3.5% to $8.46
- Closed at $8.46, +3.55% vs the prior close of $8.17. Day range $8.02–$8.53, opened at $8.41.
- Volume was 291.80K shares, 0.8x its 50-day average of 351.57K.
- Price is +18.0% vs its 50-day average ($7.17) and +74.8% vs its 200-day average ($4.84).
- 52-week range $2.59–$12.23; today's close sits at 61% of that range, 30.8% below the 52-week high.
Oct 2, 2026 — XGN jumps 3.5% to $8.17
- Closed at $8.17, +3.55% vs the prior close of $7.89. Day range $7.78–$8.20, opened at $7.99.
- Volume was 617.30K shares, 1.8x its 50-day average of 345.79K.
- Price is +15.2% vs its 50-day average ($7.09) and +69.2% vs its 200-day average ($4.83).
- 52-week range $2.59–$12.23; today's close sits at 58% of that range, 33.2% below the 52-week high.
XGN latest news & SEC filings
Every SEC filing by or about XGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Black Jeffrey G. sold 20,614 shares at $7.22 (≈$148.83K) on Sep 1, 2026
- Black Jeffrey G. sold 20,614 shares at $7.22 (≈$148.83K) on Sep 1, 2026
- Black Jeffrey G. sold 20,614 shares at $7.22 (≈$148.83K) on Sep 1, 2026
- Black Jeffrey G. sold 20,614 shares at $7.22 (≈$148.83K) on Sep 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $19.94M (prior year $17.20M) (+15.9% vs Jun 30, 2025)
- Net income: -$3.20M (prior year -$4.44M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.13 (prior year -$0.21) (loss narrowed vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade XGN
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 10, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.58% (largest 9.8%).
- Liquidity: about 368.48K shares (≈$2.84M) trade per day on average.
- 52-week position: $7.72 vs a range of $2.59–$12.23 (53% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 20 sales; latest: Jeffrey G. Black sold 20,614 shares on Sep 1, 2026.
- Latest filings: 10-Q Aug 4, 2026; 8-K Aug 4, 2026; 8-K Jun 9, 2026.
- Share count: 24.23M shares outstanding (Jul 30, 2026), +10.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
XGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.46 | 8.55 | 7.35 | 7.72 | 965.81K |
| Oct 15, 2026 | 8.34 | 8.63 | 8.17 | 8.56 | 393.90K |
| Oct 14, 2026 | 8.35 | 9.22 | 8.32 | 8.42 | 611.80K |
| Oct 13, 2026 | 8.18 | 8.66 | 8.13 | 8.48 | 470.00K |
| Oct 12, 2026 | 8.20 | 8.49 | 8.11 | 8.25 | 201.10K |
| Oct 9, 2026 | 8.17 | 8.55 | 7.98 | 8.42 | 251.20K |
| Oct 8, 2026 | 8.24 | 8.25 | 7.98 | 8.17 | 362.30K |
| Oct 7, 2026 | 7.98 | 8.36 | 7.89 | 8.30 | 234.90K |
| Oct 6, 2026 | 8.53 | 8.70 | 8.09 | 8.19 | 271.80K |
| Oct 5, 2026 | 8.41 | 8.53 | 8.02 | 8.46 | 291.80K |
| Oct 2, 2026 | 7.99 | 8.20 | 7.78 | 8.17 | 617.30K |
| Oct 1, 2026 | 8.13 | 8.25 | 7.81 | 7.89 | 401.70K |
| Sep 30, 2026 | 8.39 | 8.41 | 8.07 | 8.13 | 214.20K |
| Sep 29, 2026 | 8.55 | 8.56 | 8.24 | 8.30 | 217.80K |
| Sep 28, 2026 | 8.65 | 8.69 | 8.45 | 8.48 | 231.00K |
| Sep 25, 2026 | 8.82 | 8.89 | 8.60 | 8.72 | 282.00K |
| Sep 24, 2026 | 8.44 | 8.86 | 8.28 | 8.74 | 341.40K |
| Sep 23, 2026 | 8.77 | 8.77 | 8.25 | 8.55 | 383.80K |
| Sep 22, 2026 | 8.71 | 8.88 | 8.52 | 8.74 | 264.40K |
| Sep 21, 2026 | 8.59 | 8.70 | 8.36 | 8.62 | 361.30K |
About Exagen
Exagen (XGN) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in VISTA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1274737.
XGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Aballi | President and CEO | Mar 16, 2026 |
| Scott D Kahn | Director | Jun 22, 2026 |
| Paul Kim | Director | Aug 19, 2026 |
| Chas Mckhann | Director | Jun 22, 2026 |
| Bruce C Robertson | Director | Aug 24, 2026 |
| Frank Stokes | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Aballi | President and CEO | Mar 16, 2026 |
| Jeffrey G. Black | Chief Financial Officer | Sep 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Jeffrey G. Black | Sale | 20,614 | $7.22 |
| Sep 1, 2026 | Jeffrey G. Black | Sale | 20,614 | $7.22 |
| Sep 1, 2026 | Jeffrey G. Black | Sale | 20,614 | $7.22 |
| Sep 1, 2026 | Jeffrey G. Black | Sale | 20,614 | $7.22 |
| Mar 3, 2026 | John Aballi | Sale | 15,698 | $3.62 |
| Mar 3, 2026 | John Aballi | Sale | 15,698 | $3.62 |
| Mar 3, 2026 | John Aballi | Sale | 15,698 | $3.62 |
| Mar 3, 2026 | John Aballi | Sale | 15,698 | $3.62 |
| Feb 24, 2026 | John Aballi | Sale | 11,430 | $3.61 |
| Feb 24, 2026 | John Aballi | Sale | 11,430 | $3.61 |
| Feb 24, 2026 | John Aballi | Sale | 11,430 | $3.61 |
| Feb 24, 2026 | John Aballi | Sale | 11,430 | $3.61 |
| Feb 24, 2026 | Jeffrey G. Black | Sale | 1,584 | $3.61 |
| Feb 24, 2026 | Jeffrey G. Black | Sale | 1,584 | $3.61 |
| Feb 24, 2026 | Jeffrey G. Black | Sale | 1,584 | $3.61 |
XGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $66.58M | $-19.95M | -0.93 | $-13.62M |
| Dec 31, 2024 | $55.64M | $-15.12M | -0.83 | $-13.28M |
| Dec 31, 2023 | $52.55M | $-23.69M | -1.34 | $-14.46M |
| Dec 31, 2022 | $45.56M | $-47.39M | -2.77 | $-32.14M |
| Dec 31, 2021 | $48.30M | $-26.85M | -1.68 | $-20.27M |
Latest balance sheet: total assets $51.94M, total liabilities $39.72M, cash $24.59M (as of Jun 30, 2026).
XGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $6.45 |
| May 11, 2026 | 8-K Item 2.02 (results) | $3.98 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $3.25 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $5.95 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $10.77 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $8.45 |
| May 5, 2025 | 8-K Item 2.02 (results) | $6.25 |
| Mar 11, 2025 | 8-K Item 2.02 (results) | $3.37 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $3.12 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $2.79 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.